BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 346219)

  • 21. Transient cerebral dysfunction following chemotherapy for osteogenic sarcoma.
    Allen JC; Rosen G
    Ann Neurol; 1978 May; 3(5):441-4. PubMed ID: 310278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical observations on the use of high-dose methotrexate treatment in osteogenic sarcoma (author's transl)].
    Kotz R; Leber H; Ramach W; Arbes H; Wolf A
    Wien Klin Wochenschr; 1977 Jul; 89(14):474-9. PubMed ID: 70889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Aggressive cytostatic treatment of osteogenic sarcoma in childhood (author's transl)].
    Pontz BF; Gutjahr P
    Dtsch Med Wochenschr; 1981 Feb; 106(7):200-7. PubMed ID: 6937343
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of high-dose methotrexate and vincristine on ovarian and testicular functions in patients undergoing postoperative adjuvant treatment of osteosarcoma.
    Shamberger RC; Rosenberg SA; Seipp CA; Sherins RJ
    Cancer Treat Rep; 1981; 65(9-10):739-46. PubMed ID: 6791818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overall results of adjuvant chemotherapy and a chemosensitivity test for osteosarcoma.
    Tomita K; Tsuchiya H; Nomura S
    Clin Ther; 1989; 11(1):135-42. PubMed ID: 2720724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Osteogenic sarcoma of the limbs: value of intra-arterial chemotherapy before surgery. Preliminary results].
    Pouillart P; Palangie T; Dorval T; Berthau N; Daugu M; Coutant M; Forest M; Courpied JP; Tomeno B
    Pathol Biol (Paris); 1992 Nov; 39(9):952-3. PubMed ID: 1538949
    [No Abstract]   [Full Text] [Related]  

  • 27. cis-Dichlorodiammineplatinum (II) in advanced osteogenic sarcoma.
    Ochs JJ; Freeman AI; Douglass HO; Higby DS; Mindell ER; Sinks LF
    Cancer Treat Rep; 1978 Feb; 62(2):239-45. PubMed ID: 346212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant therapy of osteosarcoma--A Phase II trial: Southwest Oncology Group study 9139.
    Zalupski MM; Rankin C; Ryan JR; Lucas DR; Muler J; Lanier KS; Budd GT; Biermann JS; Meyers FJ; Antman K
    Cancer; 2004 Feb; 100(4):818-25. PubMed ID: 14770440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Preoperative adjuvant therapy for primary malignant bone tumors].
    Goto T; Okuma T; Nakada I; Hozumi T; Kondo T
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1750-4. PubMed ID: 18030009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative regional chemotherapy and rapid-fraction irradiation for sarcomas of the soft tissue and bone.
    Denton JW; Dunham WK; Salter M; Urist MM; Balch CM
    Surg Gynecol Obstet; 1984 Jun; 158(6):545-51. PubMed ID: 6587604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity.
    Bacci G; Ferrari S; Tienghi A; Bertoni F; Mercuri M; Longhi A; Fiorentini G; Forni C; Bacchini P; Rimondini S; De Giorgi U; Picci P
    Eur J Surg Oncol; 2001 Feb; 27(1):98-104. PubMed ID: 11237499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraarterial Cisplatin and intravenous adriamycin in nonmetastatic osteosarcoma of the extremities: a single institution experience in Taiwan.
    Chiu TJ; Wang JW; Chen YJ; Tang Y; Huang CH
    Chang Gung Med J; 2009; 32(1):72-80. PubMed ID: 19292942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of osteogenic sarcoma. I. Effect of adjuvant high-dose methotrexate after amputation.
    Rosenburg SA; Chabner BA; Young RC; Seipp CA; Levine AS; Costa J; Hanson TA; Head GC; Simon RM
    Cancer Treat Rep; 1979 May; 63(5):739-51. PubMed ID: 313245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transfer factor versus combination chemotherapy: a preliminary report of a randomized postsurgical adjuvant treatment study in osteogenic sarcoma.
    Ivins JC; Ritts RE; Pritchard DJ; Gilchrist GS; Miller GC; Taylor WF
    Ann N Y Acad Sci; 1976; 277(00):558-74. PubMed ID: 1087138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.
    Bacci G; Longhi A; Versari M; Mercuri M; Briccoli A; Picci P
    Cancer; 2006 Mar; 106(5):1154-61. PubMed ID: 16421923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perioperative chemotherapy for primary sarcoma of bone.
    Chan KW; Knowling M; Beauchamp CP
    Can J Surg; 1989 Jan; 32(1):43-6. PubMed ID: 2910379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Local en bloc resection for limb preservation.
    Jaffe N; Watts H; Fellows KE; Vawter G
    Cancer Treat Rep; 1978 Feb; 62(2):217-23. PubMed ID: 346210
    [No Abstract]   [Full Text] [Related]  

  • 38. Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients.
    Bacci G; Longhi A; Cesari M; Versari M; Bertoni F
    Cancer; 2006 Jun; 106(12):2701-6. PubMed ID: 16691623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
    Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
    J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Progress and stagnation in chemotherapy protocols for primary osteosarcoma].
    Delépine N; Alkallaf S; Cornille H; Markowska B; Delépine G
    Ann Med Interne (Paris); 2003 Feb; 154(1):12-24. PubMed ID: 12746655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.